InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Explore the complete record of transactions filed by Islam Saqib, Chairman & CEO. Director active across 2 companies, notably SpringWorks Therapeutics, Inc.. Cumulatively, 12 reports have been logged. Total volume traded: €10.6m. The latest transaction was filed on 7 January 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
€198,2993,996 shares@ €49.62433.4% of flow
Common Stock
SEC:0001104659-22-004461·
€198,2993,996 shares@ €49.62431.7% of flow
Common Stock
SEC:0001104659-22-004461:0·
€292,4365,893 shares@ €49.62435.1% of flow
Common Stock
SEC:0001104659-22-003143·
€292,4365,893 shares@ €49.62432.5% of flow
Common Stock
SEC:0001104659-22-003143:0·
78,370 shares
Common Stock
SEC:0001104659-22-002754·
78,370 shares
Common Stock
SEC:0001104659-22-002754:0·
€507,53010,083 shares@ €50.33538.8% of flow
Common Stock
SEC:0001104659-21-128168·
€507,53010,083 shares@ €50.33534.4% of flow
Common Stock
SEC:0001104659-21-128168:0·
€2m38,340 shares@ €50.45233.5% of flow
Common Stock
SEC:0001104659-21-127704·
€2m38,340 shares@ €50.45216.8% of flow
Common Stock
SEC:0001104659-21-127704:0·
€3m43,928 shares@ €64.515949.1% of flow
Common Stock
SEC:0001104659-21-094094·
€3m43,928 shares@ €64.515924.6% of flow
Common Stock
SEC:0001104659-21-094094:0·
12 of 12 declarations
About Islam Saqib
Saqib Islam is the Chief Executive Officer of SpringWorks Therapeutics, Inc. He leads the company with an innovation-driven vision in the biopharmaceutical sector. Under his leadership, SpringWorks is committed to developing innovative treatments for patients. Saqib Islam is recognized for his strategic leadership and ability to turn ideas into therapeutic solutions.
